TCL Archive President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel June 1, 2001
TCL Archive Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer May 5, 1995
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006